Preclinical models demonstrate that omega-3 supplementation enhances resistance to oxidative damage and reduces pancreatic inflammation by modulation of the cytokine response—increasing anti-inflammatory cytokines like IL-10 and reducing IL-6 and IL-8, which correlates with histopathological and clinical improvement [175,176,177]. The gene discussed is IL10; the disease is inflammatory response.